Last updated on
Adopting Telemedicine and Digital Tools for Nonvalvular Atrial Fibrillation Management and Stroke Prevention
ACTIVITY DESCRIPTION/STATEMENT OF NEED
In this activity, two experts in cardiovascular medicine discuss the benefits of telemedicine when screening and caring for patients with nonvalvular atrial fibrillation (NVAF).
This activity has been designed to meet the educational needs of primary care physicians, cardiologists, nurse practitioners, nurses, physician assistants, pharmacists, and other clinicians involved in the care of patients with NVAF.
Upon completion of this activity, participants will be able to:
- Identify the benefits of using telemedicine and remote care services to diagnose and manage patients with NVAF
- Describe ways in which telemedicine and remote care services can be used to increase patient awareness about the risks of NVAF and overcome healthcare disparities to improve healthcare delivery for patients with untreated NVAF
- Operationalize best practices to design processes and procedures for a telemedicine or remote care program to manage patients with NVAF and prevent stroke
- Employ telemedicine and remote care services to diagnose and manage patients with NVAF during the COVID-19 pandemic and beyond
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and the North American Thrombosis Forum. Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is developed with our educational partner, PVI, PeerView Institute for Medical Education.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Continuing Professional Development
Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hour(s) and 0.3 contact hour(s) in the area of pharmacology.
Continuing Pharmacy Education
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The Medical Learning Institute, Inc. (MLI) designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0468-9999-21-001-H01-P
Type of Activity: Application
This activity is supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.
RELEASE AND EXPIRATION DATES: March 12, 2021 – March 11, 2022
FACULTY DISCLOSURES AND COI
In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Khaldoun G. Tarakji, MD, MPH
Associate Professor of Medicine
Associate Section Head, Cardiac Electrophysiology
Director, Center for Digital Health and Telemedicine
Heart and Vascular Institute
Khaldoun G. Tarakji, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AliveCor, Inc.; Janssen Pharmaceuticals, Inc.; and Medtronic.
Honorarium from Bristol Myers Squibb
Rod Passman, MD, MSCE, FACC, FHRS
Jules J. Reingold Professor of Electrophysiology
Professor of Medicine and Preventive Medicine
Associate Director, Cardiac Electrophysiology
Director, Center for Arrhythmia Research
Northwestern University Feinberg School of Medicine
Rod Passman, MD, MSCE, FACC, FHRS, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Medtronic.
Grant/Research Support from Abbott.
Other Financial or Material Support in the form of royalties from UptoDate.
Planning Committee Disclosures
Tracy L. Greene, MSN, RN, FNP-C, Nurse Planner, MLI, has nothing to disclose.
Teresa Haile, RPh, MBA, Pharmacy Planner, MLI, has nothing to disclose.
The planners from Medical Learning Institute, Inc., the accredited provider, the North American Thrombosis Forum, the joint provider, and PVI, PeerView Institute for Medical Education, our educational partner, do not have any financial relationships with an ACCME-defined commercial interest related to the content of this accredited activity during the past 12 months unless listed below.
Margery Tamas, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant for Fresenius Medical Care North America.
Content/Peer Reviewer Disclosures
The following Content/Peer Reviewers have nothing to disclose:
Donald J. DiPette, MD, FACP, FAHA
Stacy L. Sims, MSN, RN, CMCN
Jorge García, MS, MHA, MBA, FACHE
Generic Disclosure Statement
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
INSTRUCTIONS FOR ACTIVITY COMPLETION
In order to receive credit, learners must participate in the entire activity. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you upon completion. You will receive your certificate from [email protected] If you have questions regarding the receipt of your emailed certificate, please contact via email at [email protected].
If requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
For nurses, the post-test and evaluation are required in their entirety and a score of 70% or higher is needed to obtain Nursing Continuing Professional Development (NCPD) contact hours.
For pharmacists, upon receipt of the completed activity evaluation, you will receive an email from [email protected]email.peerviewpress.com within 2 weeks. MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.